Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens
Authors:
- S. FilippiSFS. Filippi
- M. MariniMMM. Marini
- L. VignozziLVL. Vignozzi
- F. MontorsiFMF. Montorsi
- F. LottiF. Lotti
Open Access
- 1 February 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 11 (2) , 107-115
Abstract
The molecular mechanisms underlying the regulation of vas deferens (VD) motility and semen emission are still poorly understood. We now report evidence on VD expression of phosphodiesterase type 5 (PDE5), which regulates nitric oxide (NO)-induced relaxation and cGMP breakdown in smooth muscle cells. In human VD, the PDE5 abundance was relatively high (>3 × 106 molecules/μg total RNA), although 10-fold lower than in corpora cavernosa (CC). Also cGMP metabolising activity was higher in CC than in VD. However, both tissues share the same sensitivity to a broad panel of cGMP-related PDE inhibitors: sildenafil, tadalafil, dipyridamole, zaprinast, vinpocetine, EHNA and cilostamide. Based on the rank order of potency of these PDE inhibitors, we found that the cGMP metabolizing activity in human VD mostly corresponds to PDE5. PDE5 was immunolocalized in all the muscular layers of human and rabbit VD and was found to be negatively involved in regulating NO-induced relaxation. In addition, by using a rabbit model of hypogonadotropic hypogonadism, we found that PDE5 gene expression and activity are androgen-dependent in VD, as previously demonstrated in CC. In fact, the sensitivity to a NO-donor (NCX4040), its enhancement by PDE5 inhibitors and the PDE5-related cGMP breakdown were all affected by androgen manipulation. Our results provide a hypothesis explaining the beneficial effects of PDE inhibitors in patients with rapid ejaculation.Keywords
This publication has 38 references indexed in Scilit:
- Phosphodiesterase 5 Inhibitors in Rapid EjaculationDrugs, 2004
- Lack of functional estrogen receptor β gene disrupts pubertal male sexual behaviorHormones and Behavior, 2003
- Cyclic Nucleotide Phosphodiesterase 5 and Sildenafil: Promises RealizedMolecular Pharmacology, 2003
- Sildenafil does not improve sexual function in men without erectile dysfunction but does reduce the postorgasmic refractory timeInternational Journal Of Impotence Research, 2003
- Endothelium-dependency of yohimbine-induced corpus cavernosum relaxationInternational Journal Of Impotence Research, 2002
- Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation by Abdel-Hamid et alInternational Journal Of Impotence Research, 2001
- Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculationInternational Journal Of Impotence Research, 2001
- SSI Grand Master Lecture 6 ‘The epidemiology of erectile dysfunction: results from the National Health and Social Life Survey’International Journal Of Impotence Research, 1999
- Sexual behavior in male rats after nitric oxide synthesis inhibitionPhysiology & Behavior, 1996
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976